Login / Signup

Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study.

Takeshi YamashitaYoshiyuki IgawaMasayuki FukuzawaTakuya HayashiStefanie HennigKen Okumura
Published in: Thrombosis and haemostasis (2024)
 PK data support edoxaban 15 mg once daily for very elderly NVAF patients with high bleeding risk, with caution for patients with SRI and/or low body weight.
Keyphrases